About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Denosumab
(Xgeva, XGEVA)

[1] Denosumab (Xgeva, XGEVA) 💬

[1] TNFSF11 💬

[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬

[10] 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬

Disease ID	Name
46	Malignant rheumatoid arthritis
50	Dermatomyositis
70	Spinal stenosis
75	Cushing disease
77	Growth hormone secreting pituitary adenoma
93	Primary biliary cholangitis
95	Autoimmune hepatitis
96	Crohn disease
274	Osteogenesis Imperfecta
299	Cystic fibrosis

2

Denosumab - - immunoglobulin G2 human monoclonal antibody TO rank ligand
(Xgeva, XGEVA)

[1] Denosumab (Xgeva, XGEVA) 💬

[1] TNFSF11 💬

[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬

[1] 274 💬

3

Denosumab - immunoglobulin G2 human monoclonal antibody TO rank ligand
(Xgeva, XGEVA)

[1] Denosumab (Xgeva, XGEVA) 💬

[1] TNFSF11 💬

[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬

[1] 274 💬

4

[1] Denosumab (Xgeva, XGEVA) 💬

[1] TNFSF11 💬

[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬

[1] 274 💬

5

Xgeva - 120 MG - soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) - 1.7 ML 4 flaconcini

[1] Denosumab (Xgeva, XGEVA) 💬

[1] TNFSF11 💬

[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬

[1] 274 💬